Skip to main content
SpringerLink
Log in
Book cover

New Therapeutic Strategies in Lung Cancers pp 1–11Cite as

Lung Cancer Screening

  • Chapter
  • First Online:

  • 1354 Accesses

Abstract

Lung cancer kills more people than any other cancer. Prevention and smoking cessation remains the prime methods to reduce this death toll. The US National Lung Screening Trial (NLST), comparing computed tomography (CT) screening with chest X-ray, yielded a 20 % mortality advantage to individuals in the CT arm. The US Preventive Services Task Force have recommended the implementation of lung cancer screening in individuals of 55 to 80 year of age, based on the NLST selection criteria. However, there is currently an international debate on the how to implement lung cancer screening. Questions on cost-effectiveness need to been answered satisfactorily. The other major outstanding questions which need to be considered are focused on, in this chapter: risk prediction models to identify individuals for CT screening programmes; radiological protocols which utilise volumetric analysis for indeterminate nodules; screening interval and duration of screening. In Europe we need to prepare for lung cancer screening with an integrated smoking cessation policy, as this combined approach will save more lives than any other lung cancer intervention in the near future.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C, Doll R. Mortality from smoking worldwide. Br Med Bull. 1996;52:12–21.

    Article  PubMed  CAS  Google Scholar 

  2. IACR, UICC, CRUK. World cancer factsheet. 2012. http://infocancerresearchuk.org/cancerstats/mortality/.

  3. Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol. 2010;40:281–5.

    Article  PubMed  Google Scholar 

  4. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2:593–602.

    Article  PubMed  Google Scholar 

  5. Parkin DM. 2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer. 2011;105 Suppl 2:S6–13.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827–39.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012;48:1957–68.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6:e17479.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol. 2012;176:573–85.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Field JK, Duffy SW. Lung cancer screening: the way forward. Br J Cancer. 2008;99:557–62.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

    Article  PubMed  Google Scholar 

  12. American Lung Association. Providing Guidance on Lung Cancer Screening to Patients and Physicians. 2012. http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf.

  13. Jacobson FL, Austin JH, Field JK, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg. 2012;144:25–32.

    Article  PubMed  Google Scholar 

  14. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144:33–8.

    Article  PubMed  Google Scholar 

  15. National Comprehensive Cancer Network. NCCN Guidelines V1. 2013 Lung cancer Screening. 2013. http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf.

  16. Wender R, Fontham ET, Barrera Jr E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63:106–17.

    Article  Google Scholar 

  17. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive services task force recommendation. Ann Intern Med. 2013;159:411–20.

    Article  PubMed  Google Scholar 

  18. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728–36.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood). 2012;31:770–9.

    Article  Google Scholar 

  20. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6:1841–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report. J Thorac Oncol. 2012;7:10–9.

    Article  PubMed  Google Scholar 

  22. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306:1865–73.

    Article  PubMed  CAS  Google Scholar 

  23. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet. 2003;362:593–7.

    Article  PubMed  Google Scholar 

  24. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT Baseline results of the randomized DANTE trial. Lung Cancer. 2008;59(3):355–63.

    Article  PubMed  Google Scholar 

  25. Blanchon T, Brechot JM, Grenier PA, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007;58:50–8.

    Article  PubMed  Google Scholar 

  26. Lopes Pegna A, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009;64:34–40.

    Article  PubMed  Google Scholar 

  27. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221–9.

    Article  PubMed  Google Scholar 

  28. Pedersen J, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol. 2009;5:608–14.

    Article  Google Scholar 

  29. Becker N, Motsch E, Gross ML, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012;138:1475–86.

    Article  PubMed  CAS  Google Scholar 

  30. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax. 2011;66:308–13.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Infante M, Cavuto S, Lutman F, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180:445–53.

    Article  PubMed  Google Scholar 

  32. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21:308–15.

    Article  PubMed  Google Scholar 

  33. Field JK, Hansell DM, Duffy SW, Baldwin DR. CT screening for lung cancer: countdown to implementation. Lancet Oncol. 2013;14:e591–600.

    Article  PubMed  Google Scholar 

  34. Field J, van Klaveren R, Pedersen J, et al. European Randomised lung cancer screening trials: Post NLST. J Surg Oncol. 2013;108(5):280–6.

    Article  PubMed  Google Scholar 

  35. Field JK, Chen Y, Marcus MW, McRonald FE, Raji OY, Duffy SW. The contribution of risk prediction models to early detection of lung cancer. J Surg Oncol. 2013;108:304–11.

    Article  PubMed  Google Scholar 

  36. van Klaveren RJ, de Koning HJ, Mulshine J, Hirsch FR. Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer. 2002;38:243–52.

    Article  PubMed  Google Scholar 

  37. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95:470–8.

    Article  PubMed  Google Scholar 

  38. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008;1:250–4.

    Article  Google Scholar 

  39. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer. 2008;98:270–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  40. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369:245–54.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  41. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007;99:715–26.

    Article  PubMed  Google Scholar 

  42. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst. 2011;103:1058–68.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK. Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer. Int J Oncol. 2006;28:1295–301.

    PubMed  Google Scholar 

  44. Raji OY, Duffy SW, Agbaje OF, et al. Predictive accuracy of the Liverpool lung project risk model for stratifying patients for computed tomography screening for lung cancer: a case–control and cohort validation study. Ann Intern Med. 2012;157:242–50.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Peres J. Lung cancer screening gets risk-specific. J Natl Cancer Inst. 2013;105:1–2.

    Article  PubMed  Google Scholar 

  46. McRonald FE, Yadegarfar G, Baldwin DR, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila). 2014;7(3):362–71.

    Article  Google Scholar 

  47. Field JK, Devaraj A, Baldwin DR, et al. UK lung Cancer Screening trial (UKLS): prevalence data at baseline. Lung Cancer. 2014;83:S24–5.

    Article  Google Scholar 

  48. Xie X, Zhao Y, Snijder RA, et al. Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study. Eur Radiol. 2013;23:139–47.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet. 2013;382:732–41.

    Article  PubMed  Google Scholar 

  50. Heuvelmans MA, Oudkerk M, de Bock GH, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol. 2013;23:1836–45.

    Article  PubMed  Google Scholar 

  51. Henschke CI, Yip R, Yankelevitz DF, Smith JP. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2013;158:246–52.

    Article  PubMed  Google Scholar 

  52. Centers for Disease Control and Prevention. Cigarette smoking among adults -United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56:1157–61.

    Google Scholar 

  53. Chang B, Hwang J, Choi Y, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest. 2013;143:172–8.

    Article  PubMed  Google Scholar 

  54. Duffy SW, Field JK, Allgood PC, Seigneurin A. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer. 2014;110(7):1834–40.

    Article  PubMed  CAS  Google Scholar 

  55. Taylor KL, Shelby R, Gelmann E, McGuire C. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. J Natl Cancer Inst. 2004;96:1083–94.

    Article  PubMed  Google Scholar 

  56. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making. 2008;28:917–25.

    Article  PubMed  Google Scholar 

  57. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010;65:600–5.

    Article  PubMed  Google Scholar 

  58. van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J. 2011;37:1466–73.

    Article  PubMed  Google Scholar 

  59. Aggestrup LM, Hestbech MS, Siersma V, Pedersen JH, Brodersen J. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open. 2012;2:e000663.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Clinical Cancer Medicine, The University of Liverpool Cancer Research Centre, Institute of Translational Medicine, Roy Castle Building, 200 London Rd, Liverpool, L3 9TA, UK

    John K. Field PhD, FRCPath

Authors
  1. John K. Field PhD, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John K. Field PhD, FRCPath .

Editor information

Editors and Affiliations

  1. Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

    Solange Peters

  2. Pathologie thoracique, Institut Gustave Roussy, Villejuif, France

    Benjamin Besse

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Field, J.K. (2015). Lung Cancer Screening. In: Peters, S., Besse, B. (eds) New Therapeutic Strategies in Lung Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-06062-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06062-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06061-3

  • Online ISBN: 978-3-319-06062-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation